Axcelis Technologies, Inc. $ACLS Shares Sold by Quantbot Technologies LP

Quantbot Technologies LP lessened its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report) by 54.2% during the third quarter, HoldingsChannel reports. The institutional investor owned 16,156 shares of the semiconductor company’s stock after selling 19,122 shares during the quarter. Quantbot Technologies LP’s holdings in Axcelis Technologies were worth $1,577,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also made changes to their positions in ACLS. Royal Bank of Canada raised its position in shares of Axcelis Technologies by 3.8% during the 1st quarter. Royal Bank of Canada now owns 117,566 shares of the semiconductor company’s stock valued at $5,838,000 after acquiring an additional 4,324 shares in the last quarter. AQR Capital Management LLC increased its stake in Axcelis Technologies by 4.9% during the first quarter. AQR Capital Management LLC now owns 35,717 shares of the semiconductor company’s stock valued at $1,774,000 after purchasing an additional 1,678 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Axcelis Technologies by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,396 shares of the semiconductor company’s stock worth $963,000 after purchasing an additional 849 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Axcelis Technologies by 7.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock worth $31,560,000 after buying an additional 44,275 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Axcelis Technologies by 1.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 78,756 shares of the semiconductor company’s stock valued at $3,912,000 after buying an additional 836 shares during the period. 89.98% of the stock is currently owned by institutional investors.

Axcelis Technologies Price Performance

Shares of NASDAQ:ACLS opened at $85.91 on Friday. The firm’s 50 day moving average is $88.05 and its two-hundred day moving average is $85.88. The firm has a market capitalization of $2.64 billion, a P/E ratio of 22.67, a PEG ratio of 10.35 and a beta of 1.78. The company has a current ratio of 4.77, a quick ratio of 3.11 and a debt-to-equity ratio of 0.04. Axcelis Technologies, Inc. has a 52 week low of $40.40 and a 52 week high of $102.93.

Axcelis Technologies (NASDAQ:ACLSGet Free Report) last issued its quarterly earnings data on Tuesday, February 17th. The semiconductor company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.37. Axcelis Technologies had a return on equity of 13.73% and a net margin of 14.33%.The business had revenue of $238.33 million during the quarter, compared to analyst estimates of $215.04 million. During the same period in the prior year, the company posted $1.54 EPS. The business’s revenue for the quarter was down 5.6% compared to the same quarter last year. Axcelis Technologies has set its Q1 2026 guidance at 0.710-0.710 EPS. Analysts anticipate that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on ACLS shares. Bank of America increased their price objective on shares of Axcelis Technologies from $90.00 to $100.00 and gave the stock an “underperform” rating in a research note on Tuesday, January 13th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axcelis Technologies in a report on Monday, December 22nd. B. Riley Financial dropped their price target on Axcelis Technologies from $94.00 to $91.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 18th. Zacks Research lowered Axcelis Technologies from a “hold” rating to a “strong sell” rating in a research report on Friday, February 20th. Finally, Wall Street Zen downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, January 3rd. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $101.50.

View Our Latest Analysis on ACLS

Insider Buying and Selling at Axcelis Technologies

In other news, EVP Gerald M. Blumenstock sold 3,034 shares of the firm’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $89.46, for a total transaction of $271,421.64. Following the transaction, the executive vice president directly owned 18,661 shares of the company’s stock, valued at approximately $1,669,413.06. This trade represents a 13.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jorge Titinger sold 2,000 shares of Axcelis Technologies stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $86.05, for a total transaction of $172,100.00. Following the sale, the director owned 7,477 shares in the company, valued at approximately $643,395.85. This represents a 21.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 6,034 shares of company stock valued at $523,522. Company insiders own 0.48% of the company’s stock.

Axcelis Technologies Company Profile

(Free Report)

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

Read More

Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report).

Institutional Ownership by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.